NSE filing, NSE: THELEELA. Summary written from the filing by ALFA Finder's alert engine.
Leela Palaces Hotels & Resorts Ltd: key numbers
- Share price
- ₹609.50
- Market cap
- ₹20,355 Cr
- Revenue (annual)
- ₹1,527 Cr
- Net profit (annual)
- ₹403.1 Cr
- P/E (TTM)
- 44.0×Sector 43.7×
- Promoter holding
- 75.91%+0.00% QoQ
- FII holding
- 7.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Leela Palaces Hotels & Resorts Ltd
All →Leela Palaces Hotels & Resorts Annual General Meeting
Company seeks shareholder approval via postal ballot for material related party transactions with Leela BKC Holdings Private Limited. The voting period ends on November 15, 2026.
Leela Palaces Hotels & Resorts Earnings Call Transcript: Key Takeaways
Leela delivered a high-quality quarter, leveraging the BRICS summit and rising luxury demand to expand margins through significant premiumization.
Leela Palaces Hotels & Resorts Investor Presentation: Key Takeaways
The Leela delivered a strong Q2FY27 with 33% operating revenue growth and 36% EBITDA growth. Strategy focuses on luxury scaling, asset-light management, and high-profile event premiumization.
Leela Palaces Hotels & Resorts Results Update
Leela Palaces Q2 FY27 revenue grew 33% to ₹4,119 Cr; EBITDA rose 36% to ₹1,877 Cr. PAT up 27% to ₹946 Cr on record ADR growth.
Leela Palaces Hotels & Resorts Q2 FY27 Results: Net Profit ₹94.6 Cr, Up 26.6% YoY
Leela Palaces Hotels & Resorts Ltd reported revenue from operations of ₹411.9 Cr (+32.6% YoY) and net profit of ₹94.6 Cr (+26.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹94.6 Cr · +26.6% YoY
Leela Palaces Hotels & Resorts Board Meeting Date
Leela Palaces Hotels & Resorts Limited will hold a board meeting on October 14, 2026, to approve its quarterly and half-yearly financial results.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.